Consensus Statements on Definition, Components and Grading of Postoperative Pulmonary Complications
Launched by ACADEMISCH MEDISCH CENTRUM - UNIVERSITEIT VAN AMSTERDAM (AMC-UVA) · Apr 1, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, part of a project called PrECiSIOn, is focused on improving how we understand and manage postoperative pulmonary complications (PPCs), which are breathing problems that can occur after surgery. An international group of experts is working to create a clear definition of these complications, rank them by how serious they are, and find the best ways to monitor patients after surgery. The goal is to help doctors identify and address the most critical issues quickly, ensuring better care for patients recovering from surgery.
Currently, the trial is not recruiting participants, but it will involve healthcare professionals with significant experience in fields like Anesthesiology, Surgery, or Intensive Care Medicine. To be part of this expert panel, individuals should have at least ten years of experience caring for patients with postoperative complications or have published studies related to these issues. This trial aims to enhance the understanding of PPCs, ultimately benefiting patients and families by leading to more effective monitoring and treatment strategies after surgery.
Gender
ALL
Eligibility criteria
- • Inclusion Criteria: Panellists will be identified based on either of the following criteria
- • At least 10 years of clinical experience as a staff member in Anesthesiology, Surgery or Intensive Care Medicine with involvement in care of patients with postoperative complications
- • Author of at least three publications (observational studies or randomised controlled trials) using postoperative pulmonary complications as a primary or secondary outcome
- • Exclusion Criteria
- • - None
About Academisch Medisch Centrum Universiteit Van Amsterdam (Amc Uva)
The Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) is a leading academic medical center in the Netherlands, dedicated to advancing healthcare through innovative research, education, and patient care. Affiliated with the University of Amsterdam, AMC-UvA integrates clinical practice with cutting-edge biomedical research, fostering a multidisciplinary approach to medical challenges. The institution actively engages in clinical trials to enhance treatment options and improve patient outcomes, while promoting collaboration among healthcare professionals, researchers, and academic institutions globally. With a commitment to excellence and a focus on translational medicine, AMC-UvA plays a pivotal role in shaping the future of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Marcus Schultz, PhD
Study Chair
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported